These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15912842)

  • 1. [Possible applications for immunoglobulin G].
    Krankenpfl J; 2005; 43(1-3):52-3. PubMed ID: 15912842
    [No Abstract]   [Full Text] [Related]  

  • 2. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
    Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
    Dalakas MC
    Ann Neurol; 2002 Jun; 51(6):667-9. PubMed ID: 12112069
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment in multiple sclerosis.
    Achiron A; Cohen IR; Lider O; Melamed E
    Isr J Med Sci; 1995 Jan; 31(1):7-9. PubMed ID: 7836053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Appropriate method of apheresis in Guillain-Barré syndrome].
    Ito H; Saito T; Sakai F
    Rinsho Shinkeigaku; 1999 Nov; 39(11):1168-70. PubMed ID: 10689945
    [No Abstract]   [Full Text] [Related]  

  • 6. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    DiMario FJ
    Pediatrics; 2005 Jul; 116(1):226-8. PubMed ID: 15995056
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
    Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
    Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin.
    Fokkink WJ; Selman MH; Wuhrer M; Jacobs BC
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):105-7. PubMed ID: 25546781
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of methylprednisolone in patients with Guillain-Barré syndrome.
    Susuki K; Yuki N
    Lancet; 2004 Apr; 363(9416):1236-7; author reply 1237-8. PubMed ID: 15081664
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare case of Guillain-Barre syndrome with pregnancy.
    Vijayaraghavan J; Vasudevan D; Sadique N; Rajeswari KS; Pondurangi M; Jayshree
    J Indian Med Assoc; 2006 May; 104(5):269-70. PubMed ID: 17058576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin G is effective in multiple sclerosis].
    Favrbo K
    Ugeskr Laeger; 2005 Jan; 167(1):81; author reply 81. PubMed ID: 15675176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous immunoglobulin therapy in neuroimmunological disorders].
    Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome associated with scrub typhus.
    Lee SH; Jung SI; Park KH; Choi SM; Park MS; Kim BC; Kim MK; Cho KH
    Scand J Infect Dis; 2007; 39(9):826-8. PubMed ID: 17701724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high-dose immunoglobulin therapy for childhood Guillain-Barré syndrome.
    Zafeiriou DI; Kontopoulos EE; Katzos GS; Gombakis NP; Kanakoudi FG
    J Child Neurol; 1999 Jul; 14(7):480-1. PubMed ID: 10573477
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
    Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
    Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Easing the course of Guillain-Barré syndrome.
    Worsham TL
    RN; 2000 Mar; 63(3):46-50; quiz 52. PubMed ID: 10765378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.